The Patent Finder

Terms ending in 2039

Theravance, Inc.

Every in-force patent on Theravance, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,048,692Methods for Treating Chronic Obstructive Pulmonary Disease
In force
 · Medium confidence
Theravance Biopharma R&D IP, LLCIn forceMedium confidence
US 12,285,417Methods for Treating Chronic Obstructive Pulmonary Disease
In force
 · Medium confidence
Theravance Biopharma R&D IP, LLCIn forceMedium confidence
US 10,836,7635 to 7 Membered Heterocyclic Amides as Jak Inhibitors
In force
 · High confidence
Theravance Biopharma R&D IP, LLCIn forceHigh confidence
US 10,947,229Dimethyl Amino Azetidine Amides as Jak Inhibitors
In force
 · High confidence
Theravance Biopharma R&D IP, LLCIn forceHigh confidence
US 11,713,3155 to 7 Membered Heterocyclic Amides as Jak Inhibitors
In force
 · Low confidence
Theravance Biopharma R&D IP, LLCIn forceLow confidence
US 12,398,135Dimethyl Amino Azetidine Amides as Jak Inhibitors
In force
 · Low confidence
Theravance Biopharma R&D IP, LLCIn forceLow confidence
US 11,634,419Dimethyl Amino Azetidine Amides as Jak Inhibitors
In force
 · Medium confidence
Theravance Biopharma R&D IP, LLCIn forceMedium confidence
US 11,484,531Methods for Treating Chronic Obstructive Pulmonary Disease
In force
 · High confidence
Theravance Biopharma R&D IP, LLCIn forceHigh confidence
8 of 8 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited